These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20071178)

  • 1. The use of zolpidem in the treatment of progressive supranuclear palsy.
    Cotter C; Armytage T; Crimmins D
    J Clin Neurosci; 2010 Mar; 17(3):385-6. PubMed ID: 20071178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of progressive supranuclear palsy showing improvement of rigidity, nuchal dystonia and autonomic failure with trazodone].
    Kato E; Takahashi S; Abe T; Kawamorita A; Tohgi H
    Rinsho Shinkeigaku; 1994 Oct; 34(10):1013-7. PubMed ID: 7834944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular motor abnormalities in progressive supranuclear palsy].
    Okuma Y; Nagashima T; Hirose K; Tanabe H; Tsubaki T; Mizuno M
    No To Shinkei; 1989 Feb; 41(2):125-32. PubMed ID: 2736143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem in progressive supranuclear palsy.
    Daniele A; Moro E; Bentivoglio AR
    N Engl J Med; 1999 Aug; 341(7):543-4. PubMed ID: 10447452
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive supranuclear palsy.
    Pourfar M; Vonsattel JP
    Sci Aging Knowledge Environ; 2004 Jul; 2004(30):dn1. PubMed ID: 15282366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy.
    Chang AY; Weirich E
    Case Rep Med; 2014; 2014():107064. PubMed ID: 25371679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
    Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolpidem therapy for movement disorders.
    Abe K
    Recent Pat CNS Drug Discov; 2008 Jan; 3(1):55-60. PubMed ID: 18221242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem in progressive supranuclear palsy.
    Mayr BJ; Bonelli RM; Niederwieser G; Költringer P; Reisecker F
    Eur J Neurol; 2002 Mar; 9(2):184-5. PubMed ID: 11882066
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of progressive supranuclear palsy].
    Finali G; Piccinin GL; Piccirilli M; Stefano E
    Clin Ter; 1989 Jun; 129(5):339-51. PubMed ID: 2569956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of gaze control after balance and eye movement training in patients with progressive supranuclear palsy: a quasi-randomized controlled trial.
    Zampieri C; Di Fabio RP
    Arch Phys Med Rehabil; 2009 Feb; 90(2):263-70. PubMed ID: 19236979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of progressive supranuclear palsy improved with tandospirone citrate].
    Iijima M; Terashi H; Iwata M
    Rinsho Shinkeigaku; 2001; 41(2-3):150-3. PubMed ID: 11481861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem in progressive supranuclear palsy.
    Dash SK
    Case Rep Neurol Med; 2013; 2013():250865. PubMed ID: 23762677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asynchronous Bell's phenomenon in progressive supranuclear palsy].
    Konagaya M; Iida M
    No To Shinkei; 1993 Aug; 45(8):765-8. PubMed ID: 8217402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity.
    Damm J; Eser D; Moeller HJ; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):516-8. PubMed ID: 20218806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
    Birdi S; Rajput AH; Fenton M; Donat JR; Rozdilsky B; Robinson C; Macaulay R; George D
    Mov Disord; 2002 Nov; 17(6):1255-64. PubMed ID: 12465065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired stuttering as an early symptom in a patient with progressive supranuclear palsy].
    Sakai K; Furui E; Komai K; Notoya M; Yamada M
    Rinsho Shinkeigaku; 2002 Feb; 42(2):178-80. PubMed ID: 12424973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.